GPC1-AS1: A Potential Drug Target and Biomarker (G100130449)
GPC1-AS1: A Potential Drug Target and Biomarker
Glycopharmacoprotein (GPC) is a family of transmembrane proteins that play a crucial role in various physiological processes in the body. One of the GPC subfamilies, GPC1-AS1, has been identified as a potential drug target and biomarker. This protein is involved in the regulation of mitochondrial function and has been implicated in a range of diseases, including obesity, type 2 diabetes, and neurodegenerative disorders.
GPC1-AS1 functions as a protein that can interact with various intracellular signaling pathways, including the TOR signaling pathway. This pathway is involved in the regulation of cell growth, metabolism, and autophagy, and is a key regulator of energy metabolism. GPC1-AS1 has been shown to play a role in the regulation of mitochondrial function, including the expression of mitochondrial genes involved in energy metabolism and the control of mitochondrial size.
GPC1-AS1 is also involved in the regulation of cellular stress responses, which are critical for maintaining cellular homeostasis in response to various environmental stressors, such as oxidative stress, inflammation, and infection. The GPC1-AS1-mediated signaling pathway is thought to help cells adapt to stress conditions and maintain cellular stability.
In addition to its role in cellular stress responses, GPC1-AS1 is also implicated in the regulation of cellular adhesion and migration. This protein has been shown to play a role in the regulation of tight junction formation and the maintenance of cell-cell adhesion, which are critical for the regulation of cellular behavior and the development of various diseases, including cancer.
GPC1-AS1 is also involved in the regulation of inflammation, which is a critical aspect of the immune response and is implicated in a range of diseases, including autoimmune disorders and neurodegenerative disorders. This protein has been shown to play a role in the regulation of inflammatory responses and has been implicated in the development of various inflammatory diseases.
GPC1-AS1 has also been shown to play a role in the regulation of cellular longevity and the control of cell death. This protein has been shown to play a role in the regulation of cellular senescence, which is the process by which cells undergo dysfunction and death, and has been implicated in the development of various age-related diseases, including cancer.
GPC1-AS1 is also involved in the regulation of the blood-brain barrier, which is responsible for the regulation of the movement of substances into and out of the brain. This protein has been shown to play a role in the regulation of the blood-brain barrier and has been implicated in the development of various neurological disorders, including Alzheimer's disease.
In conclusion, GPC1-AS1 is a protein that has been shown to play a critical role in a range of physiological processes in the body. Its involvement in the regulation of mitochondrial function, cellular stress responses, inflammation, cellular adhesion, and longevity, as well as its involvement in the regulation of the blood-brain barrier, make it an attractive target for drug development. Further research is needed to fully understand the role of GPC1-AS1 in various physiological processes and to develop effective treatments for diseases associated with its dysfunction.
Protein Name: GPC1 Antisense RNA 1
The "GPC1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPC1-AS1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GPC2 | GPC3 | GPC4 | GPC5 | GPC5-AS1 | GPC5-AS2 | GPC6 | GPC6-AS1 | GPC6-AS2 | GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75
